| Financial Year |
March 31 2023 |
| Monetary Funds |
1,275,163,424.63 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
4,085,000.00 |
| Accounts Receivable |
1,717,798,918.55 |
| Advances to Suppliers |
136,980,503.07 |
| Other Receivables |
11,751,665.01 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,801,484,626.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
22,373,386.27 |
| Total Current Assets |
5,293,606,373.80 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
17,992,599.65 |
| Investment Properties |
-- |
| Fixed Assetes |
5,122,433,742.22 |
| Under-construction Projects |
1,564,109,353.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
409,926,661.96 |
| R&D expenses |
-- |
| Goodwill |
61,851,723.71 |
| Long-Term Deferred and Prepaid Expenses |
24,441,230.95 |
| Deferred Income Tax Assets |
93,914,309.36 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
7,386,291,411.07 |
| Total Assets |
12,679,897,784.87 |
| Short-Term Loans |
1,034,188,113.47 |
| Trading Financial liabilities |
-- |
| Notes Payable |
658,551,524.64 |
| Accounts Payable |
1,171,362,876.77 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
97,872,514.43 |
| Taxes Payable |
24,733,753.75 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
237,089,157.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
346,025,941.23 |
| Other Current Liabilities |
5,110,805.74 |
| Sub-Total of Current Liabilities |
3,614,248,577.79 |
| Long-term Loans |
939,912,684.74 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
294,909,366.36 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
157,617,596.53 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,692,180,454.92 |
| Total Liabilities |
5,306,429,032.71 |
| Paid-In Capital(Or Share Stock) |
850,397,292.00 |
| Capital Surplus |
4,067,342,436.66 |
| Surplus Reserve |
226,094,411.33 |
| LESS:Treasury Stock |
300,000,000.00 |
| Undistributed Profits |
2,089,064,606.55 |
| Minority Stockholder's Interest |
440,614,130.72 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,932,854,621.44 |
| Owner's Equity（Stockholder's Equity） |
7,373,468,752.16 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,679,897,784.87 |
